SHH · 600488.SS
Tianjin Tianyao Pharmaceuticals Co., Ltd.
CN¥4.73-CN¥0.04 (-0.84%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.96% below the high.
Loading market information…
SHZ · 000919.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jinling Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 39.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jinling Pharmaceutical Company Limited’s forward annual dividend is CN¥0.10 per share, paid annual. The forward yield is 1.69% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jinling Pharmaceutical Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥4.73-CN¥0.04 (-0.84%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.96% below the high.
CN¥10.44+CN¥0.20 (+1.95%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
CN¥7.16+CN¥0.06 (+0.85%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.89% below the high.
CN¥8.07+CN¥0.08 (+1.0%)
Beijing Beilu Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.09% below the high.
CN¥7.37-CN¥0.04 (-0.54%)
LanZhou Foci Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.12% below the high.
CN¥4.55-CN¥0.09 (-1.94%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CN¥8.37CN¥0.00 (0.0%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.55% below the high.
CN¥9.84-CN¥0.10 (-1.01%)
Harbin Medisan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.9% below the high.
